Recorlev (levoketoconazole) — Point32Health
endogenous hypercortisolism secondary to Cushing’s disease in adults
Initial criteria
- Documented diagnosis of hypercortisolemia secondary to Cushing’s disease
- AND Patient age ≥ 18 years
- AND Prescribing physician is an endocrinologist
- AND Documentation that surgery (e.g., pituitary, adrenal) is not an option OR has not been curative
Reauthorization criteria
- Documented diagnosis of hypercortisolemia secondary to Cushing’s disease
- AND Patient age ≥ 18 years
- AND Prescribing physician is an endocrinologist
- AND Documentation of a reduction in baseline 24-hour urinary free cortisol levels
Approval duration
initial 3 months; reauth 12 months